Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
CVS Health Corp
(NY:
CVS
)
56.94
+0.47 (+0.83%)
Official Closing Price
Updated: 7:00 PM EDT, Sep 10, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about CVS Health Corp
< Previous
1
2
...
10
11
12
13
14
15
16
17
18
...
40
41
Next >
2 Top Stocks to Buy Near Their 52-Week Lows
September 14, 2023
They are down but not out.
Via
The Motley Fool
3 S&P 500 Stocks to Sell Before a Crash
September 13, 2023
Here's a list of S&P 500 stocks to sell. Each has a unique reason behind its bearish thesis, prompting investors to take action.
Via
InvestorPlace
Topics
Stocks
Exposures
US Equities
Cramer Says 'I Have No Idea What's Happening' To A Once-Favored Stock Down 35% YTD
September 13, 2023
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Edwards Lifesciences Corporation (NYSE: EW) used to be "one of the greatest stocks of our time and, it’s now
Via
Benzinga
These 3 Health Care Stocks With Over 3% Dividend Yields Are Recommended By Wall Street's Most Accurate Analysts
September 13, 2023
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high...
Via
Benzinga
CVS And Cigna Charge $6,000 For $55 Generics, How Do We Fix This?
September 12, 2023
Health insurers dramatically mark up prices of generics and pharmacies are in on the scheme.
Via
Talk Markets
Looking Into CVS Health's Recent Short Interest
September 04, 2023
Via
Benzinga
Amazon Stock ‘Has Something For Everyone’ - Gina Sanchez
September 03, 2023
Via
Talk Markets
11 Analysts Have This to Say About CVS Health
September 01, 2023
Via
Benzinga
FDA Panel Says Popular OTC Cold, Allergy Medicine Might Be Useless - Stocks To Watch
September 12, 2023
According to FDA panel experts who reviewed the latest research on the long-questioned phenylephrine, a drug ingredient used in several leading decongestants used by millions of Americans looking for...
Via
Benzinga
Exposures
Product Safety
CVS, Walgreens Boots Among Firms Receiving Warning Letter Against Selling Unapproved Eye Products
September 12, 2023
The FDA has issued warning letters to eight companies for manufacturing or marketing unapproved ophthalmic drug products violating fed
Via
Benzinga
Exposures
Product Safety
S&P 500: Tesla, Apple Chipmaker Lead Big Movers
September 11, 2023
Aerospace giant RTX led losers on the benchmark index Monday.
Via
Investor's Business Daily
Topics
Stocks
Exposures
US Equities
10 Health Care Stocks With Whale Alerts In Today's Session
September 11, 2023
Via
Benzinga
Check Out What Whales Are Doing With CVS
August 29, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 12, 2023
September 12, 2023
Via
Benzinga
Another Arthritis Blockbuster Drug Faces Generic Competition: Novartis' Sandoz Inks Pact With Samsung Bioepis
September 11, 2023
Sandoz, a generic and biosimilar medicines unit of Novartis AG (NYSE: NVS), has
Via
Benzinga
Walmart Contemplates Multi-billion Dollar Majority Stake In ChenMed
September 09, 2023
Walmart Inc. (NYSE: WMT) is reportedly contemplating the
Via
Benzinga
The 3 Best Safe Stocks to Buy Now: September 2023
September 08, 2023
Buying safe stocks despite the market looking healthy is a wise investment decision because there are still signs a recession could occur.
Via
InvestorPlace
Topics
Economy
Exposures
Economy
If You'd Invested $25,000 in CVS Health 20 Years Ago, This Is How Much You Would Have Today
September 07, 2023
Your investment grew nicely, but would investing in CVS have been a better move than simply going with the S&P 500?
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
3 Dow Stocks to Sell in September Before They Crash and Burn
September 04, 2023
Despite the Dow's reputation of consisting of only solid, blue-chip stocks, these three are proving risky and making the list of Dow stocks to sell.
Via
InvestorPlace
Topics
Stocks
Exposures
US Equities
2 Underappreciated Dividend Stocks to Buy in September and Hold Forever
September 03, 2023
After falling significantly in recent weeks, these excellent dividend stocks look like screaming buys.
Via
The Motley Fool
Could CVS Make a Copy of Ozempic?
September 02, 2023
Given its new biosimilars unit, copying Ozempic is more likely than it sounds.
Via
The Motley Fool
CVS Health Just Created a New Problem For Viatris. Here's What You Need to Know
September 01, 2023
CVS just fired a shot across Viatris' bow.
Via
The Motley Fool
CVS Just Made a Major New Announcement, But Should You Buy It?
September 01, 2023
Spinning up a new division will probably be a boon for shareholders.
Via
The Motley Fool
Is Federal Realty Investment Trust a Buy?
September 01, 2023
It's a great company, but the yield is nothing special.
Via
The Motley Fool
3 Undervalued Healthcare Stocks In 2023
August 31, 2023
These 3 undervalued healthcare stocks in 2023 are attractive today for their attractive valuations and total return potential.
Via
Talk Markets
Now or Never: 7 Blue-Chip Stocks Offering a Once-in-a-Lifetime Opportunity
August 29, 2023
If you're looking for a once-in-a-lifetime investment opportunity, consider these seven blue-chip stocks to buy now.
Via
InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
August 28, 2023
Via
Benzinga
Wall Street's Most Accurate Analysts Say Hold These 3 Health Care Stocks With Over 3% Dividend Yields
August 28, 2023
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high...
Via
Benzinga
Boeing's 737 Deliveries Delay Due To Supplier Spirit Aerosystems, Petco Health and Wellness Stock Tumbles, AstraZeneca Under Legal Lens: Today's Top Stories
August 24, 2023
Benzinga
Via
Benzinga
Topics
Supply Chain
Exposures
Boeing 737
Supply Chain
Cheaper Version Of Blockbuster Arthritis Treatment Humira - CVS Health Teams With Sandoz
August 24, 2023
CVS Health Corp (NYSE: CVS) has launched Cordavis, a wholly-owned subsidiary, to work directly with manufacturers to commercialize and/or co-produce biosimilar
Via
Benzinga
< Previous
1
2
...
10
11
12
13
14
15
16
17
18
...
40
41
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.